Drug Characteristics
  • Formulation

    100mg tablets

    Co formulated with Lopinavir as Kaletra

  • Dose

    100-200mg daily in 1 or 2 doses in conjuction with other protease inhibitors 

  • Side Effects

    Diahorrea, prolonged QT interval, rash

  • Interactions

    significant interactions with many other drugs , check drug interactions app 

  • Renal
  • Hepatic

    avoid in hepatic impairment 

  • Pregnancy

    FDA category C

    Ritonavir should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

  • Other Information

    Signs and symptoms suggestive of pancreatitis (including raised serum lipase) should be evaluated—discontinue if pancreatitis diagnosed